The effects of an Hsp90 inhibitor on the paradoxical effect

Japanese Journal of Infectious Diseases

Volumn 62, Issue 5, 2009, Pages 392-393

  Kaneko, Yukihiro ^a   Ohno, Hideaki ^a   Imamura, Yoshifumi ^b   Kohno, Shigeru ^b   Miyazaki, Yoshitsugu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CYCLOSPORIN A; HEAT SHOCK PROTEIN 90; MICAFUNGIN; RADICICOL; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; BIOASSAY; CANDIDA ALBICANS; CULTURE MEDIUM; DRUG POTENTIATION; FUNGAL STRAIN; FUNGICIDE TOLERANCE; FUNGUS GROWTH; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; ECHINOCANDINS; ENZYME INHIBITORS; FUNGI; HSP90 HEAT-SHOCK PROTEINS; LIPOPEPTIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 72849119385     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ruhnke, M., Hartwig, K. and Kofla, G. (2008): New options for treatment of candidaemia in critically ill patients. Clin. Microbiol. Infect., 14 (Suppl. 4), 46-54.
2. Carrillo-Munoz, A.J., Giusiano, G., Ezkurra, P.A., et al. (2006): Antifungal agents: mode of action in yeast cells. Rev. Esp. Quimioter., 19, 130-139.
3. Wiederhold, N.P. (2007): Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Curr. Opin. Infect. Dis., 20, 574-578.
4. Wiederhold, N.P., Kontoyiannis, D.P., Prince, R.A., et al. (2005): Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother., 49, 5146-5148.
5. Walker, L.A., Munro, C.A., de Bruijn, I., et al. (2008): Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog., 4, e1000040.
6. Jones, T., Federspiel, N.A., Chibana, H., et al. (2004): The diploid genome sequence of Candida albicans. Proc. Natl. Acad. Sci. USA, 101, 7329-7334.
7. Melo, A.S., Colombo, A.L. and Arthington-Skaggs, B.A. (2007): Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob. Agents Chemother., 51, 3081-3088.
8. Truman, A.W., Millson, S.H., Nuttall, J.M., et al. (2007): In the yeast heat shock response, Hsf1-directed induction of Hsp90 facilitates the activation of the Slt2 (Mpk1) mitogen-activated protein kinase required for cell integrity. Eukaryot. Cell, 6, 744-752.
9. Stevens, D.A., Ichinomiya, M., Koshi, Y., et al. (2006): Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother., 50, 3160-3161.
10. Cowen, L.E. and Lindquist, S. (2005): Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science, 309, 2185-2189.
11. Singh, S.D., Robbins, N., Zaas, A.K., et al. (2009): Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog., 5, e1000532.
12. Kanafani, Z.A. and Perfect, J.R. (2008): Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin. Infect. Dis., 46, 120-128.
13. Chamilos, G., Lewis, R.E., Albert, N., et al. (2007): Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob. Agents Chemother., 51, 2257-2259.
14. Lewis, R.E., Albert, N.D. and Kontoyiannis, D.P. (2008): Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J. Antimicrob. Chemother., 61, 1140-1144.
15. Clemons, K.V., Espiritu, M., Parmar, R., et al. (2006): Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob. Agents Chemother., 50, 1293-1297.
16. Wiederhold, N.P., Kontoyiannis, D.P., Chi, J., et al. (2004): Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J. Infect. Dis., 190, 1464-1471.
17. Stevens, D.A., Espiritu, M. and Parmar, R. (2004): Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother., 48, 3407-3411.